A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β(2)-adrenergic agonist, in asthma; a Phase II, randomized study

BACKGROUND: Long-acting β(2)-adrenergic agonists (LABAs) are recommended in combination with inhaled corticosteroids (ICSs) for asthma management. Abediterol is a novel, selective, potent, once-daily LABA in development for treatment of asthma and chronic obstructive pulmonary disease. This study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Dave, Pujol, Helena, Ribera, Anna, Seoane, Beatriz, Massana, Eric, Astbury, Carol, Ruiz, Sandrine, de Miquel, Gonzalo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320624/
https://www.ncbi.nlm.nih.gov/pubmed/25398689
http://dx.doi.org/10.1186/1471-2466-14-176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320624/
https://www.ncbi.nlm.nih.gov/pubmed/25398689
http://dx.doi.org/10.1186/1471-2466-14-176

Ejemplares similares